Cite
MLA Citation
James F Howard et al.. “Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial.” Lancet neurology, vol. 20, no. 7, 2021, pp. 526–536. http://access.bl.uk/ark:/81055/vdc_100164328386.0x000007